Dil Afroze
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Epigenetics and DNA Methylation 6
- Muscle Physiology and Disorders 3
-
- Cancer-related molecular mechanisms research 6
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Ashok Kumar (2 shared papers)Bilal Rah (12 shared papers)Ifra Mushtaq (6 shared papers)Gh Rasool Bhat (6 shared papers)Abdul Basit Baba (3 shared papers)Sabra Parveen (2 shared papers)Zafar A. Shah (13 shared papers)Sajedah M. Hindi (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Gene (2 papers)Frontiers in Genetics (2 papers)Frontiers in Pharmacology (2 papers)Immunological Investigations (2 papers)
- Partner nations
- IndiaUnited StatesUnited Arab Emirates
In The Last Decade
Dil Afroze
54 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 156
- Oncology 164
- Molecular Biology 445
- Aging 11
- Immunology 112
Countries citing papers authored by Dil Afroze
This map shows the geographic impact of Dil Afroze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dil Afroze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dil Afroze more than expected).
Fields of papers citing papers by Dil Afroze
This network shows the impact of papers produced by Dil Afroze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dil Afroze. The network helps show where Dil Afroze may publish in the future.
Co-authors
The 25 scholars most cited alongside Dil Afroze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 145 | |
| 2 | 2017 | 119 | |
| 3 | 2022 | 106 | |
| 4 | 2017 | 78 | |
| 5 | Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics. | 2021 | 40 |
| 6 | Cancer immunotherapy: a promising dawn in cancer research. | 2020 | 35 |
| 7 | 2013 | 31 | |
| 8 | 2014 | 29 | |
| 9 | 2015 | 27 | |
| 10 | 2012 | 25 | |
| 11 | NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. | 2010 | 25 |
| 12 | 2018 | 24 | |
| 13 | 2010 | 22 | |
| 14 | 2018 | 20 | |
| 15 | 2012 | 20 | |
| 16 | 2021 | 19 | |
| 17 | 2014 | 19 | |
| 18 | 2014 | 17 | |
| 19 | 2022 | 16 | |
| 20 | 2015 | 15 |
About Dil Afroze
Dil Afroze is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Surgery, having authored 57 papers that have together received 1.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer-related Molecular Pathways (5 papers), Telomeres, Telomerase, and Senescence (3 papers), Muscle Physiology and Disorders (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (156 citations), Oncology (164 citations), Molecular Biology (445 citations), Aging (11 citations) and Immunology (112 citations). Dil Afroze has collaborated with scholars based in India, United States and United Arab Emirates. Frequent co-authors include Ashok Kumar, Bilal Rah, Ifra Mushtaq, Gh Rasool Bhat, Abdul Basit Baba, Sabra Parveen, Zafar A. Shah, Sajedah M. Hindi, Joseph D. McMillan and Rafiq A. Rather. Their work appears in journals such as Frontiers in Oncology, Gene, Frontiers in Genetics, Frontiers in Pharmacology and Immunological Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.